Cargando…

Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria

The link between plasma D-dimer levels and underlying malignancy has been established. How this translates in clinical practice as a marker of detection and prognosis of cervical cancer (CC) is still unknown. This study compared the plasma D-dimer levels in women with and without CC and assessed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tietie, Lucky E, Okunade, Kehinde S, SoibI-Harry, Adaiah P, John-Olabode, Sarah O, Anorlu, Rose I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937069/
https://www.ncbi.nlm.nih.gov/pubmed/36816787
http://dx.doi.org/10.3332/ecancer.2023.1501
_version_ 1784890354766446592
author Tietie, Lucky E
Okunade, Kehinde S
SoibI-Harry, Adaiah P
John-Olabode, Sarah O
Anorlu, Rose I
author_facet Tietie, Lucky E
Okunade, Kehinde S
SoibI-Harry, Adaiah P
John-Olabode, Sarah O
Anorlu, Rose I
author_sort Tietie, Lucky E
collection PubMed
description The link between plasma D-dimer levels and underlying malignancy has been established. How this translates in clinical practice as a marker of detection and prognosis of cervical cancer (CC) is still unknown. This study compared the plasma D-dimer levels in women with and without CC and assessed the associations between plasma D-dimer levels and the stage and grade of CC. It was a comparative cross-sectional study of 65 women with histological diagnosis of CC and an equal number of age-matched cancer-free women enrolled at the University Teaching Hospital in Lagos, Nigeria. Participants’ sociodemographic and clinical data as well as venous blood samples for estimation of plasma D-dimer were collected for statistical analyses. A receiver operating characteristic (ROC) analysis is performed to select the cut-off value of plasma D-dimer for differentiating CC from non-cancer. There was a statistically significant difference in the median levels of plasma D-dimer of women with CC and their cancer-free comparison groups (3,120 (1,189–4,515) versus 210 (125–350) ng/mL; p = 0.001). A plasma D-dimer value of 543 ng/mL was chosen in a ROC analysis as the discriminatory cut-off to differentiate CC from non-cancer. There were significant associations between plasma D-dimer levels and the International Federation of Gynaecology and Obstetrics stage (p = 0.001) or grade (p = 0.001) of CC. The study, therefore, demonstrated the potential clinical usefulness of plasma D-dimer as a diagnostic and prognostic marker of CC.
format Online
Article
Text
id pubmed-9937069
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-99370692023-02-18 Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria Tietie, Lucky E Okunade, Kehinde S SoibI-Harry, Adaiah P John-Olabode, Sarah O Anorlu, Rose I Ecancermedicalscience Research The link between plasma D-dimer levels and underlying malignancy has been established. How this translates in clinical practice as a marker of detection and prognosis of cervical cancer (CC) is still unknown. This study compared the plasma D-dimer levels in women with and without CC and assessed the associations between plasma D-dimer levels and the stage and grade of CC. It was a comparative cross-sectional study of 65 women with histological diagnosis of CC and an equal number of age-matched cancer-free women enrolled at the University Teaching Hospital in Lagos, Nigeria. Participants’ sociodemographic and clinical data as well as venous blood samples for estimation of plasma D-dimer were collected for statistical analyses. A receiver operating characteristic (ROC) analysis is performed to select the cut-off value of plasma D-dimer for differentiating CC from non-cancer. There was a statistically significant difference in the median levels of plasma D-dimer of women with CC and their cancer-free comparison groups (3,120 (1,189–4,515) versus 210 (125–350) ng/mL; p = 0.001). A plasma D-dimer value of 543 ng/mL was chosen in a ROC analysis as the discriminatory cut-off to differentiate CC from non-cancer. There were significant associations between plasma D-dimer levels and the International Federation of Gynaecology and Obstetrics stage (p = 0.001) or grade (p = 0.001) of CC. The study, therefore, demonstrated the potential clinical usefulness of plasma D-dimer as a diagnostic and prognostic marker of CC. Cancer Intelligence 2023-01-30 /pmc/articles/PMC9937069/ /pubmed/36816787 http://dx.doi.org/10.3332/ecancer.2023.1501 Text en © the authors; licensee ecancermedicalscience. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Tietie, Lucky E
Okunade, Kehinde S
SoibI-Harry, Adaiah P
John-Olabode, Sarah O
Anorlu, Rose I
Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria
title Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria
title_full Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria
title_fullStr Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria
title_full_unstemmed Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria
title_short Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria
title_sort potential clinical utility of plasma d-dimer levels among women with cervical cancer in lagos, nigeria
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937069/
https://www.ncbi.nlm.nih.gov/pubmed/36816787
http://dx.doi.org/10.3332/ecancer.2023.1501
work_keys_str_mv AT tietieluckye potentialclinicalutilityofplasmaddimerlevelsamongwomenwithcervicalcancerinlagosnigeria
AT okunadekehindes potentialclinicalutilityofplasmaddimerlevelsamongwomenwithcervicalcancerinlagosnigeria
AT soibiharryadaiahp potentialclinicalutilityofplasmaddimerlevelsamongwomenwithcervicalcancerinlagosnigeria
AT johnolabodesaraho potentialclinicalutilityofplasmaddimerlevelsamongwomenwithcervicalcancerinlagosnigeria
AT anorlurosei potentialclinicalutilityofplasmaddimerlevelsamongwomenwithcervicalcancerinlagosnigeria